Page 91 - Predicting survival in patients with spinal bone metastasesL

Table 4. Results survival analysis and multivariate analysis for survival prediction categories. MOS: median overall survival. CI: confidence interval. HR: hazard ratio.
Excisional Palliative No surgery
Local control Palliative Supportive care
Long-term Middle-term Short-term Terminal
A B C
Extensive Palliative
A B C D
259 (20) 493 (37) 573 (43)
344 (25) 546 (40) 489 (35)
299 (22) 277 (20) 410 (30) 393 (28)
146 (11) 559 (42) 625 (47)
1111 (84) 216 (16)
149 (11) 318 (24) 489 (37) 374 (28)
17.9 (12.8-22.9) 8.4 (7.0-9.8) 2.7 (2.4-3.0)
18.7 (15.8-21.7) 5.9 (4.9-6.9) 2.5 (2.2-2.8)
21.8 (18.6-25.0) 5.9 (4.7-7.1) 4.9 (3.8-5.9) 2.5 (2.2-2.8)
29.8 (23.1-36.5) 9.7 (8.2-11.1) 2.5 (2.3-2.7)
6.8 (6.1-7.6) 1.8 (1.4-2.3)
29.8 (22.7-36.9) 16.5 (14.0-19.0) 4.9 (4.4-5.4) 1.7 (1.4-2.0)
-
1.6 (1.4-1.9) 3.5 (3.0-4.2)
-
2.1 (1.8-2.4) 3.8 (3.3-4.5)
-
2.2 (1.9-2.7) 2.7 (2.3-3.1) 4.3 (3.7-5.1)
-
2.3 (1.9-2.8) 5.8 (4.7-7.2)
-
2.7 (2.3-3.1)
-
1.8 (1.4-2.2) 4.1 (3.2-5.1) 9.2 (7.3-11.4)
<0.001 <0.001 <0.001
<0.001 <0.001 <0.001
<0.001 <0.001 <0.001 <0.001
<0.001 <0.001 <0.001
<0.001 <0.001
<0.001 <0.001 <0.001 <0.001
VI
SCORING SYSTEMS
Tokuhashi
N (%)
MOS, months (95%CI)
HR (95%CI)
p-value
Bauer
N (%)
MOS, months (95%CI)
HR (95%CI)
p-value
Tomita
N (%)
MOS, months (95%CI)
HR (95%CI)
p-value
Van der Linden
N (%)
MOS, months (95%CI)
HR (95%CI)
p-value
Rades
N (%)
MOS, months (95%CI)
HR (95%CI)
p-value
Bollen
N (%)
MOS, months (95%CI)
HR (95%CI)
p-value
89